Chi Podcasts

PEGS Boston 2018 | Discovery of High-Affinity Human PD-1 and LAG-3 Antibodies

Informações:

Sinopse

Cambridge Healthtech Institute’s Kent Simmons recently spoke with Dr. David Johnson, CEO of GigaGen, about his upcoming presentation “Discovery of High-Affinity Human PD-1 and LAG-3 Antibodies Using Novel Microfluidic and Molecular Genomic Methods”, to be delivered in the Engineering Antibodies meeting at the 2018 PEGS Boston. PEGS is scheduled for April 30 - May 4, 2018 in Boston, with the antibodies program set for May 2-3. For more information, please visit http://www.PEGSummit.com/Engineering-Antibodies